nedaplatin has been researched along with Adverse Drug Event in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ensom, MH; Loh, GW; Ting, LS | 1 |
| Chiba, T; Fukushima, M; Ishiguro, H; Kanai, M; Kitano, T; Matsumoto, S; Misawa, A; Mitsumori, M; Nishimura, T; Sakai, Y; Shimada, Y; Teramukai, S; Watanabe, G; Yanagihara, K; Yoshikawa, K | 1 |
1 review(s) available for nedaplatin and Adverse Drug Event
| Article | Year |
|---|---|
A systematic review of limited sampling strategies for platinum agents used in cancer chemotherapy.
Topics: Adult; Antineoplastic Agents; Area Under Curve; Bayes Theorem; Carboplatin; Child; Cisplatin; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Tests; Humans; Male; Organoplatinum Compounds; Regression Analysis | 2007 |
1 other study(ies) available for nedaplatin and Adverse Drug Event
| Article | Year |
|---|---|
Retrospective analysis of 27 consecutive patients treated with docetaxel/nedaplatin combination therapy as a second-line regimen for advanced esophageal cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug-Related Side Effects and Adverse Reactions; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Organoplatinum Compounds; Retrospective Studies; Salvage Therapy; Survival Analysis; Taxoids | 2007 |